Perfluoroalkyl substances measured in breast milk and child neuropsychological development in a Norwegian birth cohort study

Environment International

Volumn 83, Issue , 2015, Pages 176-182

  Forns, J ^a   Iszatt, N ^a   White, R A ^a   Mandal, S ^a   Sabaredzovic, A ^a   Lamoree, M ^b   Thomsen, C ^a   Haug, L S ^a   Stigum, H ^a   Eggesbo M ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Child development; Epidemiology; Nervous system; Neuropsychology; Perfluorooctane sulfonic acid; Perfluorooctanoic acid

Indexed keywords

EPIDEMIOLOGY; LOGISTIC REGRESSION; NEUROLOGY; SURVEYS;

BREAST MILK SAMPLES; CHILD DEVELOPMENT; MEDIAN CONCENTRATION; NEGATIVE BINOMIAL REGRESSION MODEL; NEUROPSYCHOLOGY; PERFLUOROALKYL SUBSTANCES; PERFLUOROOCTANE SULFONIC ACIDS; PERFLUOROOCTANOIC ACID;

DAIRIES;

PERFLUOROALKYL DERIVATIVE; PERFLUOROALKYL SUBSTANCE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; POLLUTANT;

BREASTFEEDING; CHILD DEVELOPMENT; COGNITION; COHORT ANALYSIS; EPIDEMIOLOGY; MILK; NERVOUS SYSTEM; NEUROLOGY; REGRESSION ANALYSIS; TOXIC SUBSTANCE;

AGES AND STAGES QUESTIONNAIRE II; ARTICLE; BREAST MILK; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; INFANT TODDLER SYMPTOM CHECKLIST; MALE; MENTAL DEVELOPMENT ASSESSMENT; NEUROPSYCHOLOGY; NORWAY; NORWEGIAN (PEOPLE); PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; ADULT; CHEMISTRY; DRUG EFFECTS; INFANT; MATERNAL EXPOSURE; POLLUTANT; PRESCHOOL CHILD; QUESTIONNAIRE; TOXICITY; YOUNG ADULT;

NORWAY;

ADULT; ALKANESULFONIC ACIDS; CAPRYLATES; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; INFANT; MALE; MATERNAL EXPOSURE; MILK, HUMAN; NORWAY; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84935449340     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2015.06.013     Document Type: Article

References (54)

1. Bland J.M., Altman D.G. Cronbach's alpha. BMJ 1997, 314:572.
2. Boucher O., Simard M.-N., Muckle G., Rouget F., Kadhel P., Bataille H., Chajès V., Dallaire R., Monfort C., Thomé J.-P., Multigner L., Cordier S. Exposure to an organochlorine pesticide (chlordecone) and development of 18-month-old infants. Neurotoxicology 2013, 35:162-168. 10.1016/j.neuro.2013.01.007.
3. Calafat A.M., Wong L.-Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602. 10.1289/ehp.10598.
4. Casey B.J., Tottenham N., Liston C., Durston S. Imaging the developing brain: what have we learned about cognitive development?. Trends Cogn. Sci. 2005, 9:104-110. 10.1016/j.tics.2005.01.011.
5. Chen M.-H., Ha E.-H., Liao H.-F., Jeng S.-F., Su Y.-N., Wen T.-W., Lien G.-W., Chen C.-Y., Hsieh W.-S., Chen P.-C. Perfluorinated compound levels in cord blood and neurodevelopment at 2years of age. Epidemiol. Camb. Mass 2013, 24:800-808. 10.1097/EDE.0b013e3182a6dd46.
6. Cheng Y., Cui Y., Chen H., Xie W. Thyroid disruption effects of environmental level perfluorooctane sulfonates (PFOS) in Xenopus laevis. Ecotoxicol. Lond. Engl. 2011, 20:2069-2078. 10.1007/s10646-011-0749-3.
7. D'eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environ. Sci. Technol. 2011, 45:7974-7984. 10.1021/es200171y.
8. De Cock M., de Boer M.R., Lamoree M., Legler J., van de Bor M. First year growth in relation to prenatal exposure to endocrine disruptors - a Dutch prospective cohort study. Int. J. Environ. Res. Public Health 2014, 11:7001-7021. 10.3390/ijerph110707001.
9. De Gangi G., Poisson S. Infant-toddler symptom checklist: long version, in: pediatric disorders of regulation in affect and behavior: a therapist's guide to assessment and treatment 2000, 335-340. Academic, San Diego.
10. Der G., Batty G.D., Deary I.J. Effect of breast feeding on intelligence in children: prospective study, sibling pairs analysis, and meta-analysis. BMJ 2006, 333:945. 10.1136/bmj.38978.699583.55.
11. Eggesbø M., Stigum H., Longnecker M.P., Polder A., Aldrin M., Basso O., Thomsen C., Skaare J.U., Becher G., Magnus P. Levels of hexachlorobenzene (HCB) in breast milk in relation to birth weight in a Norwegian cohort. Environ. Res. 2009, 109:559-566. 10.1016/j.envres.2009.04.001.
12. Eggesbø M., Thomsen C., Jørgensen J.V., Becher G., Odland J.Ø., Longnecker M.P. Associations between brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates. Environ. Res. 2011, 111:737-743. 10.1016/j.envres.2011.05.004.
13. Fei C., Olsen J. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7years. Environ. Health Perspect. 2011, 119:573-578. 10.1289/ehp.1002026.
14. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ. Health Perspect. 2008, 116:1391-1395. 10.1289/ehp.11277.
15. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270. 10.1016/j.ijheh.2008.04.007.
16. Fuentes S., Colomina M.T., Vicens P., Domingo J.L. Influence of maternal restraint stress on the long-lasting effects induced by prenatal exposure to perfluorooctane sulfonate (PFOS) in mice. Toxicol. Lett. 2007, 171:162-170. 10.1016/j.toxlet.2007.05.006.
17. Grandjean P., Landrigan P.J. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014, 13:330-338. 10.1016/S1474-4422(13)70278-3.
18. Gump B.B., Wu Q., Dumas A.K., Kannan K. Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ. Sci. Technol. 2011, 45:8151-8159. 10.1021/es103712g.
19. Han X., Snow T.A., Kemper R.A., Jepson G.W. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem. Res. Toxicol. 2003, 16:775-781. 10.1021/tx034005w.
20. Haug L.S., Thomsen C., Becher G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ. Sci. Technol. 2009, 43:2131-2136.
21. Haug L.S., Thomsen C., Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J. Chromatogr. A 2009, 1216:385-393. 10.1016/j.chroma.2008.10.113.
22. Haug L.S., Huber S., Becher G., Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Environ. Int. 2011, 37:687-693. 10.1016/j.envint.2011.01.011.
23. Heiberg Endresen E., Helsing E. Changes in breastfeeding practices in Norwegian maternity wards: national surveys 1973, 1982 and 1991. Acta Paediatr. Oslo Nor. 1995, 1992(84):719-724.
24. Hoffman K., Webster T.F., Weisskopf M.G., Weinberg J., Vieira V.M. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ. Health Perspect. 2010, 118:1762-1767. 10.1289/ehp.1001898.
25. Hornman J., Kerstjens J.M., de Winter A.F., Bos A.F., Reijneveld S.A. Validity and internal consistency of the Ages and Stages Questionnaire 60-month version and the effect of three scoring methods. Early Hum. Dev. 2013, 89:1011-1015. 10.1016/j.earlhumdev.2013.08.016.
26. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C.G. Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 2006, 40:3463-3473.
27. Iszatt N., van Hattum B., Hopman-Ubbels G., Eggesbø M. Organotin Compounds and Rapid Infant Growth 2015, (in preparation).
28. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008, 29:160-169. 10.1016/j.neuro.2007.10.008.
29. Jones P.D., Hu W., De Coen W., Newsted J.L., Giesy J.P. Binding of perfluorinated fatty acids to serum proteins. Environ. Toxicol. Chem. 2003, 22:2639-2649.
30. Kärrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., Lignell S., Lindström G. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ. Health Perspect. 2007, 115:226-230. 10.1289/ehp.9491.
31. Kim S.K., Lee K.T., Kang C.S., Tao L., Kannan K., Kim K.R., Kim C.K., Lee J.S., Park P.S., Yoo Y.W., Ha J.Y., Shin Y.S., Lee J.H. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut. 2011, 159:169-174. 10.1016/j.envpol.2010.09.008.
32. Lande B., Andersen L.F., Baerug A., Trygg K.U., Lund-Larsen K., Veierød M.B., Bjørneboe G.E.A. Infant feeding practices and associated factors in the first six months of life: the Norwegian infant nutrition survey. Acta Paediatr. Oslo Nor. 2003, 1992(92):152-161.
33. Lindsay N.M., Healy G.N., Colditz P.B., Lingwood B.E. Use of the Ages and Stages Questionnaire to predict outcome after hypoxic-ischaemic encephalopathy in the neonate. J. Paediatr. Child Health 2008, 44:590-595. 10.1111/j.1440-1754.2008.01388.x.
34. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., Wu Y. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ. Int. 2011, 37:1206-1212. 10.1016/j.envint.2011.05.001.
35. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148. 10.1016/j.tox.2005.07.018.
36. Mariussen E. Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance. Arch. Toxicol. 2012, 86:1349-1367. 10.1007/s00204-012-0822-6.
37. Martin J.W., Asher B.J., Beesoon S., Benskin J.P., Ross M.S. PFOS or PreFOS? Are perfluorooctane sulfonate precursors (PreFOS) important determinants of human and environmental perfluorooctane sulfonate (PFOS) exposure?. J. Environ. Monit. 2010, 12:1979-2004. 10.1039/c0em00295j.
38. MTM research center, n.d. Report 2010, PT PFC Human Milk 2009/2010. Orebro University, Sweden.
39. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305. 10.1289/ehp.10009.
40. Renner R. Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 2001, 35:154A-160A.
41. Richter J., Janson H. A validation study of the Norwegian version of the Ages and Stages Questionnaires. Acta Paediatr. Oslo Nor. 2007, 1992(96):748-752. 10.1111/j.1651-2227.2007.00246.x.
42. Royston P. Multiple imputation of missing values. Stata J. 2004, 4:227-241.
43. Seals R., Bartell S.M., Steenland K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ. Health Perspect. 2011, 119:119-124. 10.1289/ehp.1002346.
44. Skjaerven R., Gjessing H.K., Bakketeig L.S. Birthweight by gestational age in Norway. Acta Obstet. Gynecol. Scand. 2000, 79:440-449.
45. Slotkin T.A., MacKillop E.A., Melnick R.L., Thayer K.A., Seidler F.J. Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ. Health Perspect. 2008, 116:716-722. 10.1289/ehp.11253.
46. Squires J., Bricker D., Potter L. Revision of a parent-completed development screening tool: ages and stages questionnaires. J. Pediatr. Psychol. 1997, 22:313-328.
47. Squires J., Potter L., Bricker D. Ages & Stages Questionnaires (ASQ): A Parent-Completed, Child-Monitoring System 1999, Brookes Publishing, Baltimore, MD. 2nd ed.
48. Stein C.R., Savitz D.A. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. Environ. Health Perspect. 2011, 119:1466-1471. 10.1289/ehp.1003538.
49. Stein C.R., Savitz D.A., Bellinger D.C. Perfluorooctanoate and neuropsychological outcomes in children. Epidemiol. Camb. Mass 2013, 24:590-599. 10.1097/EDE.0b013e3182944432.
50. Strøm M., Hansen S., Olsen S.F., Haug L.S., Rantakokko P., Kiviranta H., Halldorsson T.I. Persistent organic pollutants measured in maternal serum and offspring neurodevelopmental outcomes-a prospective study with long-term follow-up. Environ. Int. 2014, 68:41-48. 10.1016/j.envint.2014.03.002.
51. Sundström M., Ehresman D.J., Bignert A., Butenhoff J.L., Olsen G.W., Chang S.-C., Bergman A. A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden. Environ. Int. 2011, 37:178-183. 10.1016/j.envint.2010.08.014.
52. Tao L., Kannan K., Wong C.M., Arcaro K.F., Butenhoff J.L. Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ. Sci. Technol. 2008, 42:3096-3101.
53. Thomsen C., Haug L.S., Stigum H., Frøshaug M., Broadwell S.L., Becher G. Changes in concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. Environ. Sci. Technol. 2010, 44:9550-9556. 10.1021/es1021922.
54. Zeng H.-C., Zhang L., Li Y.-Y., Wang Y.-J., Xia W., Lin Y., Wei J., Xu S.-Q. Inflammation-like glial response in rat brain induced by prenatal PFOS exposure. Neurotoxicology 2011, 32:130-139. 10.1016/j.neuro.2010.10.001.